Subscribe to The Value Anchor Topic / The Trend Catcher Topic —unlock the full historical archive and never miss a weekly pick again.

Top 3 US Stocks with the Highest Potential Upside

Detailed Analysis of Each Pick

1. Sandisk Corporation(SNDK.US) – The Structural NAND Powerhouse

• The Core Thesis: SanDisk has fundamentally changed its business model via 5 New Business Model (NBM) agreements, securing ~$62B in minimum committed revenue and over $11B in prepayments. This transforms it from a volatile spot-price NAND trader into a high-visibility, high-margin (80%+ GM) cash flow machine. NAND supply will remain tight through at least CY27.
• Key Bank View: Evercore ISI (Outperform) argues "investors are underappreciating the durability of EPS." They raised PT to $3,100.Potential Upside to Target: +85%; To Bull Case: +139%
• Why SanDisk over Others? It is the purest play on the NAND/SSD cycle. While MU has DRAM and HBM, SNDK’s entire earnings profile is being structurally re-rated by long-term contracts. The recent ~14% daily drop on July 14 offers a better entry point before the new earnings visibility is fully priced in.
• Risk: Execution of the new contracts; a faster-than-expected NAND supply recovery could hurt pricing.

2. Lumentum Holdings, Inc.(LITE.US) – The AI Optics & CPO Play

• The Core Thesis: AI data centers are moving from copper to optical interconnects to handle massive data throughput. Lumentum is a key supplier of photonic components for 800G/1.6T transceivers, which are in explosive demand. Bluefin Research expects 800G module volumes to exceed 100 million units in 2027, up from 60M in 2026. Lumentum's revenue is projected to grow from $1.6B (FY25) to $8.7B (FY28) , implying a 5x revenue ramp.
• Key Bank View: Morgan Stanley (Overweight) sets PT at $900, using 30x CY28 P/E of ~$30. They highlight that AI is becoming more embedded in their base case, and greater CPO adoption is a bull case driver. TD Cowen also maintains Buy but cut PT to $800 (still close to current price).
• Why LITE Offers ~17% Upside: The base case is conservative. If CPO (Co-Packaged Optics) adoption accelerates beyond expectations—which Morgan Stanley explicitly mentions as a bull case—the stock could re-rate substantially. The risk/reward is asymmetric: limited downside (~$600 bear case) vs. massive upside ($1,400 bull case).
• Risk: Execution on new product ramps; competition from other optical suppliers; CPO adoption may be slower than expected.

3. SpaceX(SPCX.US) – The AI & Space Double Play

• The Core Thesis: SpaceX is no longer just a rocket company. Morgan Stanley’s new coverage (July 13, 2026) values the stock using a Sum-of-the-Parts approach, with the Enterprise AI business (Grok + X) alone worth $152 per share—more than half the total valuation. The space business ($8/share), connectivity (Starlink, $128/share), and X & Grok ($12/share) round out the rest. The company is the dominant launch provider (supplying 4 out of 5 US launches per Linde data), and its Starlink business is a cash flow machine.
• Key Bank View: Morgan Stanley (Overweight) initiated coverage with a $300 price target. The valuation uses an 11.1% WACC and a 2040 ending forecast period, implying extraordinary long-term growth. The firm explicitly applies a 50% discount on the Enterprise AI valuation for execution risk, meaning the upside could be even larger if Grok monetization succeeds.
• Why SPCX Offers 100%+ Upside: The stock is currently not meaningfully covered by most sell-side analysts. Morgan Stanley’s initiation is one of the first major research reports. As more investors understand the AI revenue stream (Grok subscriptions, X API, enterprise AI services) and Starlink’s cash flow generation, the stock should re-rate. The $300 target implies +116% upside from the current price ($139), but the bull case—where Enterprise AI execution risk is lower—could push the stock to $400-$500 (up +188% to +260%).
• Risk: Execution risk on Grok monetization; regulatory uncertainty (FAA, FCC); competition from other launch providers (Blue Origin, Rocket Lab); high valuation multiples (trading at >30x forward revenue). The 50% discount on Enterprise AI valuation shows even Morgan Stanley is cautious on the AI business.

Disclaimer: The content is provided as general information only and should not be taken as investment advice. All the contents shall not be taken as a recommendation to buy or sell any security or financial instruments. Any action you take resulting from information, analysis, or commentary on this article is your responsibility. Please consult your investment advisor before making any investments.